BIJSLUITER: INFORMATIE VOOR DE GEBRUIKER. Deslorasam 5 mg filmomhulde tabletten Desloratadine

Similar documents
Package leaflet: Information for the user. Desloratadine Archie Samuel 5 mg filmomhulde tabletten Desloratadine

PACKAGE LEAFLET Page 1 of 6

Package leaflet: Information for the patient. Desloratadine Cipla 5 mg film-coated tablets. Desloratadine

B. PACKAGE LEAFLET 1

NL/H/882/ / Amlodipine CT 5 mg, tabletten Amlodipine CT 10 mg, tabletten

Package leaflet: Information for the patient. Amoxicilline/Clavulaanzuur Torrent 500 mg/125 mg filmomhulde tabletten. Amoxicillin Clavulanic acid

Package leaflet: Information for the patient

Package leaflet: Information for the user

Package leaflet: Information for the patient. Co-amoxiclav 250 mg/125 mg film-coated tablets Amoxicillin/clavulanic acid

PATIENT INFORMATION LEAFLET DYNA CEFPODOXIME 100 mg / DYNA CEFPODOXIME SUSPENSION:

1. WHAT CO-AMOXICLAV TABLETS IS AND WHAT IT IS USED FOR

Package leaflet: Information for the user

New Zealand Consumer Medicine Information

2 What you need to know before you take Augmentin

Package leaflet: Information for the patient. Co-amoxiclav 500 mg/125 mg film-coated tablets. amoxicillin/ clavulanic acid

PACKAGE LEAFLET: INFORMATION FOR THE USER

PACKAGE LEAFLET: INFORMATION FOR THE USER. AMOXICILLIN 250mg and 500mg CAPSULES BP Amoxicillin (as amoxicillin trihydrate)

Amoxicillin 250mg Hard Capsules Amoxicillin 500mg Hard Capsules

PATIENT INFORMATION LEAFLET

Package leaflet: Information for the user. Amlodipin Accord 10 mg tablets. Amlodipine

Package leaflet: Information for the patient. FLUCLOXACILLIN 250MG/5ML ORAL SOLUTION Flucloxacillin

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICATION PATIENT MEDICATION INFORMATION. Moxifloxacin tablets (as moxifloxacin hydrochloride)

Package leaflet: Information for the patient. Germentin 500 mg/125 mg film coated tablets Amoxicillin/clavulanic acid

Package leaflet: Information for the user. Amlodipin Aurobindo 10 mg tablets. Amlodipine

AMLODIPINE 5 MG TABLETS AMLODIPINE 10 MG TABLETS Amlodipine

Package leaflet: Information for the user. GENTAMICIN VISION 3 mg/ml eye drops, solution Gentamicin

AMLODIPINE GENERICHEALTH

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine 5 mg Tablets Amlodipine 10 mg Tablets (Amlodipine Besilate)

Moxifloxacin APOTEX Contains the active ingredient moxifloxacin (as hydrochloride monohydrate)

Amlodipin Bluefish 10 mg tablets. amlodipine

Package leaflet: Information for the user

PACKAGE LEAFLET: Information for the user. amlodipino cinfa 5 mg tablets

Package leaflet: Information for the user Augmentin 875 mg/125 mg film-coated tablets Amoxicillin/clavulanic acid

PACKAGE LEAFLET Page 1 of 7

OFLOXACIN TABLETS MEDICATION GUIDE

SUMMARY OF PRODUCT CHARACTERISTICS

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amikacin 250 mg/ml Injection

2. What you need to know before you take Doxycycline capsule

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine maleate. Read all of this leaflet carefully before you start taking this medicine.

MEDICATION GUIDE FLOXIN [Flox in] (ofloxacin)

Blooms The Chemist Amlodipine / Atorvastatin

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

For a copy of a large print leaflet, Ph: Read this leaflet carefully before taking your medicine.

B. PACKAGE LEAFLET 1

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE PATIENT MEDICATION INFORMATION. (HYDROmorphone Hydrochloride) Sterile Solution for Injection

PATIENT INFORMATION LEAFLET GENTAMICIN 10MG/ML SOLUTION FOR INJECTION OR INFUSION. and GENTAMICIN 40MG/ML SOLUTION FOR INJECTION OR INFUSION

Amlodipine Pfizer 5 mg and 10 mg tablets Amlodipine

Package leaflet: Information for the patient Genticin 80mg/2ml Solution for Injection Gentamicin

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. PATIENT MEDICATION INFORMATION N HYDROmorphone HP 10

READ THIS FOR SAFE AND EFFECTIVE USE OF YOUR MEDICINE. PATIENT MEDICATION INFORMATION HYDROmorphone Hydrochloride Injection USP

PACKAGE LEAFLET: INFORMATION FOR THE USER. GENTAMICIN VISION 3 mg/g eye ointment Gentamicin

Keep this leaflet with your medicine. You may want to read it again. What this medicine is used for

Excipient with known effect Each ml of oral solution contains 150 mg/ml of sorbitol, liquid (non-crystallising).

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

NL/H/880/01-02 FINAL PL

Package leaflet: Information for the user. Moxifloxacin 400 mg film-coated tablets. Adults Active substance: Moxifloxacin

FDA-Approved Medication Guide MEDICATION GUIDE Moxifloxacin Hydrochloride Tablets (mox'' i flox' a sin hye'' droe klor' ide) Rx only

PACKAGE LEAFLET: INFORMATION FOR THE USER. Amlodipine 10 mg Tablets. (Amlodipine Besilate)

Minims Chloramphenicol

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

DBL Doxycycline Doxycycline Hydrochloride (dox-i-sye-kleen)

Package leaflet: Information for the user. AUGMENTIN DUO 400 mg/57 mg/5 ml powder for oral suspension Amoxicillin/clavulanic acid

SUMMARY OF PRODUCT CHARACTERISTICS. Cephacare flavour 50 mg tablets for cats and dogs. Excipients: For a full list of excipients, see section 6.1.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Package leaflet: information for the user

uk-pl-nl0979v026-clean.doc Page 1 of 9

LABELLING AND PACKAGE LEAFLET

Antibiotics. Information for patients and carers Pharmacy Department. Patient information leaflet

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Metacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs, cats and guinea pigs.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

SUMMARY OF PRODUCT CHARACTERISTICS

PART IB1 SUMMARY OF PRODUCT CHARACTERISTICS OCTACILLIN

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

SUMMARY OF PRODUCT CHARACTERISTICS. Milprazon 16 mg/40 mg film-coated tablets for cats weighing at least 2 kg

Package leaflet: Information for the patient. Flomocin 400mg film-coated tablets Moxifloxacin

TO ENSURE ADEQUATE ABSORPTION, ALWAYS ADMINISTER PROGRAM FLAVOR TABS IN CONJUNCTION WITH A NORMAL MEAL.

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

SUMMARY OF PRODUCT CHARACTERISTICS. Active substance: cefalexin (as cefalexin monohydrate) mg

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Oral and intestinal candidiasis. As adjuvant treatment with other local nystatin preparations to prevent reinfection.

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS. Medicinal product no longer authorised

Irish Medicines Board

Veterinary Medicinal Product

PACKAGE LEAFLET: INFORMATION FOR THE USER

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

Prescription Label. Patient Name: Species: Drug Name & Strength: Directions (amount to give how often & for how long):

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

Gentamicin or Tobramycin for Peritonitis in Peritoneal Dialysis

SUMMARY OF PRODUCT CHARACTERISTICS 1.B.1 SUMMARY OF PRODUCT CHARACTERISTICS

SUMMARY OF PRODUCT CHARACTERISTICS

Therios 300 mg and 750 mg Palatable Tablets for Dogs

Summary of Product Characteristics 1. NAME OF THE VETERINARY MEDICINAL PRODUCT. Enrotab 50 mg tablets for dogs

ANNEX III AMENDMENTS TO THE SUMMARY OF PRODUCT CHARACTERISTICS AND PACKAGE LEAFLET

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS

B. PACKAGE LEAFLET 1

SUMMARY of PRODUCT CHARACTERISTICS (SPC)

Transcription:

BIJSLUITER: INFORMATIE VOOR DE GEBRUIKER Deslorasam 5 mg filmomhulde tabletten Desloratadine Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. - Keep this leaflet. You may need to read it again. - If you have any further questions, ask your doctor or pharmacist. - This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. - If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4. What is in this leaflet: 1. What Deslorasam is and what it is used for 2. What you need to know before you take Deslorasam 3. How to take Deslorasam 4. Possible side effects 5. How to store Deslorasam 6. Contents of the pack and other information 1. What Deslorasam is and what it is used for What Deslorasam is Deslorasam contains desloratadine which is an antihistamine. How Deslorasam works Deslorasam is an antiallergy medicine that does not make you drowsy. It helps control your allergic reaction and its symptoms. When Deslorasam should be used Deslorasam relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older. These symptoms include sneezing, runny or itchy nose, itchy palate, and itchy, red or watery eyes. Deslorasam is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). These symptoms include itching and hives. Relief of these symptoms lasts a full day and helps you to resume your normal daily activities and sleep. 2. What you need to know before you take Deslorasam Do not take Deslorasam if you are allergic to desloratadine or any of the other ingredients of this medicine (listed in section 6) or to loratadine. Warnings and precautions Talk to your doctor, pharmacist or nurse before taking Deslorasam: if you have poor kidney function. if you have medical or familial history of seizures. Use in children and adolescents Do not give this medicine to children less than 12 years of age.

Other medicines and Deslorasam There are no known interactions of Deslorasam with other medicines. Tell your doctor or pharmacist if you are taking/using, have recently taken/used or might take/use any other medicines. Deslorasam with food, drink and alcohol Deslorasam may be taken with or without a meal. Use caution when taking Deslorasam with alcohol. Pregnancy,breast-feeding and fertility If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. Taking Deslorasam is not recommended if you are pregnant or nursing a baby. Fertility There is no data available on male/female fertility. Driving and using machines At the recommended dose, this medicine is not expected to affect your ability to drive or use machines. Although most people do not experience drowsiness, it is recommended not to engage in activities requiring mental alertness, such as driving a car or operating machinery until you have established your own response to the medicinal product. Deslorasam contains lactose. Deslorasam film-coated tablets contain lactose.if you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product. 3. How to take Deslorasam Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure. Adults and adolescents 12 years of age and over The recommended dose is one tablet once a day with water, with or without food. This medicine is for oral use. Swallow the tablet whole. Regarding the duration of treatment, your doctor will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Deslorasam. If your allergic rhinitis is intermittent (presence of symptoms for less than 4 days per week or for less than 4 weeks), your doctor will recommend you a treatment schedule that will depend on the evaluation of the history of your disease. If your allergic rhinitis is persistent (presence of symptoms for 4 days or more per week and for more than 4 weeks), your doctor may recommend you a longer term treatment. For urticaria, the duration of treatment may be variable from patient to patient and therefore you should follow the instructions of your doctor. If you take more Deslorasam than you should Take Deslorasam only as it is prescribed for you. No serious problems are expected with accidental overdose. However, if you take more Deslorasam than you were told to tell your doctor or pharmacist immediately. If you forget to take Deslorasam If you forget to take your dose on time, take it as soon as possible and then go back to your regular dosing schedule. Do not take a double dose to make up for a forgotten dose. If you stop taking Deslorasam If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects Like all medicines, this medicine can cause side effects, although not everybody gets them. During the marketing of Deslorasam, cases of severe allergic reactions (difficulty in breathing, wheezing, itching, hives and swelling) have been reported very rarely. If you notice any of these serious side effects, stop taking the medicine and seek urgent medical advice straight away. In clinical studies in adults, side effects were about the same as with a dummy tablet. However, fatigue, dry mouth and headache were reported more often than with a dummy tablet. In adolescents, headache was the most commonly reported side effect. In clinical studies with Deslorasam, the following side effects were reported as: Common: the following may affect up to 1 in 10 people fatigue dry mouth headache Adults During the marketing of Deslorasam, the following side effects were reported as: Very rare: the following may affect up to 1 in 10,000 people severe allergic reactions rash pounding or irregular heartbeat fast heartbeat stomach ache feeling sick (nausea) vomiting upset stomach diarrhoea dizziness drowsiness inability to sleep muscle pain hallucinations seizures restlessness with increased liver inflammation abnormal liver function tests body movement Not known: frequency cannot be estimated from the available data unusual weakness yellowing of the skin and/or eyes increased sensitivity of the skin to the sun, even in case of hazy sun, and to UV light, for instance to UV lights of a solarium changes in the way the heart beats abnormal behaviour aggression weight increased increased appetite Children Not known: frequency cannot be estimated from the available data slow heartbeat changes in the way the heart beats abnormal behaviour aggression Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects you can help provide more information on the safety of this medicine. 5. How to store Deslorasam Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month. Do not store above 30 C. Store in the original package in order to protect from moisture. Do not use this medicine if you notice any change in the appearance of the tablets. Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment. 6. Contents of the pack and other information What Deslorasam contains - The active substance is desloratadine. Each film-coated tablet contains 5 mg desloratadine. - The other ingredients are: - Tablet core: poloxamer type 188, citric acid monohydrate, microcrystalline cellulose, maize starch, croscarmellose sodium, lactose monohydrate, talc. - Tablet coat: polyvinyl alcohol (part. hydrolyzed), titanium dioxide (E 171), macrogol/peg 3350 and indigo carmine aluminium lake (E 132), talc. What Deslorasam looks like and contents of the pack Deslorasam are round, biconvex, blue film-coated tablets with a diameter of 6.5 mm. The product is supplied in packs of 7, 10, 14, 15, 20, 30, 40, 50, 60, 90 and 100 film-coated tablets. Not all pack sizes may be marketed. Houder van de vergunning voor het in de handel brengen en fabrikant Houder van de vergunning voor het in de handel brengen Archie Samuel s.r.o. Slunná 16 617 00 Brno Tsjechië Fabrikant Merckle GmbH Ludwig-Merckle-Str. 3 89143 Blaubeuren Duitsland Teva Operations Poland Sp Z.o.o. ul.mogilska 80 31-546 Krakow Polen In het register ingeschreven onder RVG 109600 Dit geneesmiddel is geregistreerd in lidstaten van de EEA onder de volgende namen: Duitsland: Desloratadin AbZ 5 mg Filmtabletten Nederland: Deslorasam 5 mg filmomhulde tabletten

Deze bijsluiter is voor het laatst goedgekeurd in maand december 2017